Craig A. Wheeler - 17 Apr 2025 Form 3 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Craig Wheeler
Issuer symbol
APLS
Transactions as of
17 Apr 2025
Net transactions value
$0
Form type
3
Filing time
21 Apr 2025, 16:09:13 UTC
Previous filing
07 Jun 2024
Next filing
06 Jun 2025

No securities are beneficially owned.